Unknown

Dataset Information

0

HDL-mimetic PLGA nanoparticle to target atherosclerosis plaque macrophages.


ABSTRACT: High-density lipoprotein (HDL) is a natural nanoparticle that exhibits an intrinsic affinity for atherosclerotic plaque macrophages. Its natural targeting capability as well as the option to incorporate lipophilic payloads, e.g., imaging or therapeutic components, in both the hydrophobic core and the phospholipid corona make the HDL platform an attractive nanocarrier. To realize controlled release properties, we developed a hybrid polymer/HDL nanoparticle composed of a lipid/apolipoprotein coating that encapsulates a poly(lactic-co-glycolic acid) (PLGA) core. This novel HDL-like nanoparticle (PLGA-HDL) displayed natural HDL characteristics, including preferential uptake by macrophages and a good cholesterol efflux capacity, combined with a typical PLGA nanoparticle slow release profile. In vivo studies carried out with an ApoE knockout mouse model of atherosclerosis showed clear accumulation of PLGA-HDL nanoparticles in atherosclerotic plaques, which colocalized with plaque macrophages. This biomimetic platform integrates the targeting capacity of HDL biomimetic nanoparticles with the characteristic versatility of PLGA-based nanocarriers.

PROVIDER: S-EPMC4484871 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

2013-01-01 | S-EPMC3653172 | BioStudies
| S-EPMC5589956 | BioStudies
1000-01-01 | S-EPMC5245982 | BioStudies
2017-01-01 | S-EPMC6113536 | BioStudies
1000-01-01 | S-EPMC5339001 | BioStudies
2019-01-01 | S-EPMC6662054 | BioStudies
| S-EPMC2843502 | BioStudies
1000-01-01 | S-EPMC3574906 | BioStudies
1000-01-01 | S-EPMC2923725 | BioStudies
| S-EPMC6933811 | BioStudies